1 Department of Pediatrics Children's Medical Center University of Virginia Charlottesville, VA 22908
Ketorolac has become an important component of analgesic regimens for children as well as adults because of its lack of adverse effects on respiratory, cardiovascular, and neurologic function. Although initially used parenterally in hospitalized patients, the development of an oral ketorolac dose form extended its use to the outpatient setting, where its potency has been considered an advantage over traditional therapies.1-3
Several cases of hyperkalemia and oliguric acute renal failure associated with ketorolac use have been reported in the medical literature.4-12 Elderly hospitalized patients receiving large doses of ketorolac intramuscularly (IM) after major surgery seem to be at greatest risk.
Submitted on May 16, 1995
This article has been cited by other articles:
![]() |
C. Kallanagowdar, A. LeBreton, and D. H. Aviles Acute Renal Failure Clinical Pediatrics, October 1, 2006; 45(8): 771 - 773. [PDF] |
||||
![]() |
B. M. RuDusky Severe Postoperative Hemorrhage Attributed to Single-Dose Parenteral Ketorolac-Induced Coagulopathy Angiology, December 1, 2000; 51(12): 999 - 1002. [Abstract] [PDF] |
||||
![]() |
RENAL DISEASE FROM KETOROLAC Journal Watch (General), August 20, 1996; 1996(820): 5 - 5. [Full Text] |
||||